Pancreatic neuroendocrine tumors (NETs) are rare well-differentiated neoplasms with limited therapeutic options and unknown cells of origin. The current classification of pancreatic neuroendocrine tumors is based on proliferative grading, and guides therapeutic strategies, however, tumors within grades exhibit profound heterogeneity in clinical manifestation and outcome. Manifold studies have highlighted intra-patient differences in tumors at the genetic and transcriptomic levels. Molecular classification might become an alternative or complementary basis for treatment decisions and reflect tumor biology, actionable cellular processes. Here, we provide a comprehensive review of genomic, transcriptomic, proteomic and epigenomic studies of pancreatic NETs to elucidate patterns shared between proposed subtypes that could form a foundation for new classification. We denote four NET subtypes with distinct molecular features, which were consistently reproduced using various omics technologies.
26 October 2019 in Bulletin of Experimental Biology and Medicine
Microscopic tissue analysis is the key diagnostic method needed for disease identification and choosing the best treatment regimen. According to the Global Cancer Observatory, approximately two million people are diagnosed with colorectal cancer each year, and an accurate diagnosis requires a significant amount of time and a highly qualified pathologist to decrease the high mortality rate. Recent development of artificial intelligence technologies and scanning microscopy introduced digital pathology into the field of cancer diagnosis by means of the whole-slide image (WSI). In this work, we applied deep learning methods to diagnose six types of colon mucosal lesions using convolutional neural networks (CNNs). As a result, an algorithm for the automatic segmentation of WSIs of colon biopsies was developed, implementing pre-trained, deep convolutional neural networks of the ResNet and EfficientNet architectures. We compared the classical method and one-cycle policy for CNN training and applied both multi-class and multi-label approaches to solve the classification problem. The multi-label approach was superior because some WSI patches may belong to several classes at once or to none of them. Using the standard one-vs-rest approach, we trained multiple binary classifiers. They achieved the receiver operator curve AUC in the range of 0.80–0.96. Other metrics were also calculated, such as accuracy, precision, sensitivity, specificity, negative predictive value, and F1-score. Obtained CNNs can support human pathologists in the diagnostic process and can be extended to other cancers after adding a sufficient amount of labeled data.
Pancreatic fibrosis (PF) is a part of the pathogenesis in most pancreatic disorders and plays a crucial role in chronic pancreatitis development. The aim of our study was to investigate a relationship between PF grade and signs in resected pancreatic specimens, and the results of both multidetector computed tomography (MDCT) post-processing parameters and fibronectin (FN), hyaluronic acid (HA), matrix metalloproteinase (MMP)-1, and MMP-9 serum levels. The examination results of 74 patients were analyzed. The unenhanced pancreas density (UPD) value and contrast enhancement ratio (CER) showed statistically significant differences in groups with peri- and intralobular fibrosis grades, an integrative index of fibrosis, inflammation in pancreatic tissue, and pancreatic duct epithelium metaplasia, while the normalized contrast enhancement ratio in the venous phase (NCER VP) significantly differed with the perilobular fibrosis grade, integrative fibrosis index, and inflammation (p < 0.05). The blood FN level showed a weak positive correlation with the intralobular fibrosis grade (rho = 0.32, p = 0.008). The blood level of HA positively correlated with the presence of prominent and enlarged peripheral nerves (rho = 0.28, p = 0.02) and negatively correlated with the unenhanced pancreas density value (rho = −0.42, p = 0.0001). MMP-1 and MMP-9 values’ intergroup analysis and correlation did not show any statistical significance. The UPD value, NCER VP, and CER, as well as blood levels of FN and HA, could be used in non-invasive PF diagnosis.
1 April 2024 in Russian Journal of Evidence-Based Gastroenterology
Objective. This review provides an in-depth analysis of the current landscape in assessing pancreatic fibrosis. Key points. Pancreatic fibrosis is a common feature in various diseases, including inflammatory and neoplastic conditions, exacerbating their progression. Timely identification of fibrotic changes in pancreatic tissue plays a crucial role in halting or slowing down the advancement of glandular damage. Evaluation methods for fibrosis encompass both invasive and non-invasive approaches. Histological assessment remains the most dependable method for gauging the extent of pancreatic fibrosis. Among the numerous scales for the morphological assessment of pancreatic fibrosis, the system proposed by G. Kloppel, B. Maillet, which evaluates peri- and intralobular fibrosis along with an integrative index, currently stands out as the most applicable for research purposes. In the pursuit of novel non-invasive diagnostic methods for pancreatic tissue fibrosis, researchers are actively developing laboratory biomarkers such as matrix metalloproteinases and specific blood cytokines, as well as instrumental techniques like ultrasound, computed tomography, and magnetic resonance imaging. Conclusion. Each method possesses unique capabilities and limitations associated with the patient’s condition, the prevalence of the fibrotic process, and the presence of comorbidities. The most effective approach involves the integrated use of data obtained from an objective assessment of pancreatic tissue fibrosis. Notably, there is a current lack of standardized scales for the reproducibility of laboratory, instrumental and histological systems in assessing pancreatic fibrosis.